Cargando…
Sclerostin antibody stimulates periodontal regeneration in large alveolar bone defects
Destruction of the alveolar bone in the jaws can occur due to periodontitis, trauma or following tumor resection. Common reconstructive therapy can include the use of bone grafts with limited predictability and efficacy. Romosozumab, approved by the FDA in 2019, is a humanized sclerostin-neutralizin...
Autores principales: | Yao, Yao, Kauffmann, Frederic, Maekawa, Shogo, Sarment, Lea V., Sugai, James V., Schmiedeler, Caroline A., Doherty, Edward J., Holdsworth, Gill, Kostenuik, Paul J., Giannobile, William V. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7530715/ https://www.ncbi.nlm.nih.gov/pubmed/33004873 http://dx.doi.org/10.1038/s41598-020-73026-y |
Ejemplares similares
-
Cell‐Based Therapies for Alveolar Bone and Periodontal Regeneration: Concise Review
por: Moreno Sancho, Federico, et al.
Publicado: (2019) -
Changes in salivary biomarkers associated with periodontitis and diabetic neuropathy in individuals with type 1 diabetes
por: Steigmann, Larissa, et al.
Publicado: (2022) -
Current and future trends in periodontal tissue engineering and bone regeneration
por: Galli, Matthew, et al.
Publicado: (2021) -
Regenerative Medicine Technologies to Treat Dental, Oral, and Craniofacial Defects
por: Latimer, Jessica M., et al.
Publicado: (2021) -
3D-Printed Scaffolds and Biomaterials: Review of Alveolar Bone Augmentation and Periodontal Regeneration Applications
por: Asa'ad, Farah, et al.
Publicado: (2016)